Ramaswamy Plans $4 Million Ad Targeting Amy Acton
Vivek Ramaswamy reportedly plans to spend $4 million on an advertisement targeting Amy Acton through claims involving her estranged mother.
Trump’s “Trash Island” Golf Project Faces Legal Scrutiny
Trump calls a site linked to his proposed golf project “Trash Island,” but legal questions center on approvals, construction limits, public interests, and preservation.
Trump Gives Nick Shirley $10,000 Over Minnesota Video
Trump presented YouTuber Nick Shirley with $10,000 after his video raised allegations of fraud at Minnesota day care centers. The payment does not prove the claims.
Campaign Cash Floods Competitive Races as GOP Defends Seats
Heavy campaign spending signals that both parties see narrow margins and significant risks as Republicans defend vulnerable seats and Democrats expand the electoral map.
Xbox Game Pass Reportedly Planning a Major Overhaul
Reports suggest Xbox Game Pass could introduce à la carte options, but Microsoft has not confirmed the pricing, features, launch date, or availability.
Android 17 QPR3 Beta 2 Brings 21 Pixel Fixes
Android 17 QPR3 Beta 2 is rolling out to eligible Pixel devices with 21 reported fixes and a Quick Settings option that can lock connectivity controls.
FSR 4.1 Support Expands to Xbox Series X|S and Ally
Microsoft and AMD are bringing FSR 4.1 upscaling to Xbox Series X|S and Xbox Ally, giving developers more options to balance image quality, performance, and power efficiency.
Pennsylvania Warns of Measles Risks During Pregnancy
Pennsylvania officials warn about measles during pregnancy and rare congenital or perinatal infection. Learn the symptoms, risks, prevention steps, and when to seek care.
Google Brings Personalized Gemini AI to Cars
Google is bringing a more personalized Gemini AI assistant to cars, with Android Auto expected to provide hands-free help for navigation, messaging, reminders, and more.
AI-Created Virus Treatment: What We Know
A reported treatment using an AI-created virus raises questions about clinical evidence, patient safety, regulation, dual-use risks, and independent verification.